Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-09-08
DOI
10.1093/eurheartj/ehab618
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
- (2021) Tamara A Sussman et al. Journal for ImmunoTherapy of Cancer
- Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
- (2021) Daniel A Zlotoff et al. Journal for ImmunoTherapy of Cancer
- Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials
- (2021) Elisa Agostinetto et al. EUROPEAN JOURNAL OF CANCER
- Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
- (2021) Paaladinesh Thavendiranathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials
- (2021) Joe-Elie Salem et al. EUROPEAN JOURNAL OF CANCER
- Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies
- (2020) Janice M. Bonsu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
- (2020) Charles Dolladille et al. Journal for ImmunoTherapy of Cancer
- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- Identification of anticancer drugs associated with atrial fibrillation - analysis of the WHO pharmacovigilance database
- (2020) Joachim Alexandre et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors
- (2020) Ohad Oren et al. AMERICAN JOURNAL OF CARDIOLOGY
- Improving the Efficacy of Liver Cancer Immunotherapy: the Power of Combined Preclinical and Clinical Studies
- (2020) Gen‐Sheng Feng et al. HEPATOLOGY
- Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque
- (2020) Zsofia D. Drobni et al. CIRCULATION
- The cancer patient and cardiology
- (2020) José Luis Zamorano et al. EUROPEAN JOURNAL OF HEART FAILURE
- Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience
- (2020) L. Gutierrez-Sainz et al. Clinical & Translational Oncology
- The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study
- (2020) Maria D’Souza et al. EUROPEAN HEART JOURNAL
- Practical cardiovascular imaging approach to diagnose immune checkpoint inhibitor myocarditis
- (2020) Lavanya Kondapalli et al. European Heart Journal-Cardiovascular Imaging
- Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database
- (2020) Pierre-Marie Morice et al. Lancet Haematology
- Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication
- (2019) Stephane Ederhy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular Toxicities of Immune Checkpoint Inhibitors
- (2019) Somedeb Ball et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event
- (2019) Jennifer Cautela et al. CANADIAN JOURNAL OF CARDIOLOGY
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
- (2018) Melanie Calvert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events
- (2017) Jean-Luc Faillie et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology
- (2017) Journal of Oncology Practice
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications
- (2014) Daniel M. Hartung et al. ANNALS OF INTERNAL MEDICINE
- Programmed Cell Death-1 Deficiency Exacerbates T Cell Activation and Atherogenesis despite Expansion of Regulatory T Cells in Atherosclerosis-Prone Mice
- (2014) Clément Cochain et al. PLoS One
- Relative risks versus odds ratios
- (2014) P. Sedgwick BMJ-British Medical Journal
- Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation
- (2011) De-xiu Bu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations
- (2011) Tarek A Hammad et al. Clinical Trials
- Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
- (2011) Stephen J. Nicholls et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation
- (2010) Heiko Bugger et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started